PEMIGATINIB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where PEMIGATINIB was used for Bladder cancer.
Most Reported Side Effects for PEMIGATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 114 | 16.1% | 28 | 19 |
| Disease progression | 103 | 14.5% | 38 | 13 |
| Death | 76 | 10.7% | 76 | 6 |
| Fatigue | 72 | 10.2% | 5 | 7 |
| Alopecia | 53 | 7.5% | 2 | 5 |
| Hyperphosphataemia | 46 | 6.5% | 10 | 11 |
| Cholangiocarcinoma | 44 | 6.2% | 19 | 4 |
| Diarrhoea | 42 | 5.9% | 0 | 10 |
| Constipation | 37 | 5.2% | 2 | 4 |
| Drug ineffective | 37 | 5.2% | 13 | 3 |
| Hospitalisation | 35 | 4.9% | 0 | 34 |
| Nausea | 35 | 4.9% | 5 | 5 |
| Decreased appetite | 34 | 4.8% | 3 | 5 |
| Stomatitis | 31 | 4.4% | 2 | 6 |
| Dry mouth | 30 | 4.2% | 1 | 2 |
Other Indications for PEMIGATINIB
Cholangiocarcinoma (431)
Bile duct cancer (34)
Glioblastoma (12)
Adenocarcinoma of salivary gland (10)
Pancreatic carcinoma (8)
Malignant lymphoid neoplasm (7)
Hepatic cancer (5)
Myeloproliferative neoplasm (5)
Neoplasm malignant (5)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)